Universidade Nove de Julho
São Paulo, 01504-001, Brazil
Location status: Recruiting
Location contact
Raphael Dias
CONTACT
NCT Number: NCT06168006
The aim of this study is to assess the effect of a physical exercise program via a mobile application on functional parameters in individuals with post-COVID-19 syndrome. This is a clinical trial involving 60 individuals with post-COVID syndrome who will be randomly assigned to either a control group (physical activity guideline) or an experimental group (app-based training).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
São Paulo, 01504-001, Brazil
Location status: Recruiting
Raphael Dias
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The experimental group will undergo an exercise program using the Recovery App. Participants will receive guidance from researchers about the functionality of the app. The Recovery App includes flexibility, strength, and aerobic training exercises, aiming for a progressive intensity and volume over the weeks.
Other names: Rehabilitation, Physical activity, Endurance, Resistance exercises
They will receive an exercise booklet based on the Brazilian Physical Activity Recommendations (MINISTRY OF HEALTH, 2021), which recommend 150 minutes of physical activity for adults and seniors.
Time frame: Baseline and 12 weeks
The 6-minute walk test performed in a 30-meter corridor, measured in meters
Time frame: Baseline and 12 weeks
The test consists in rise from a chair, carry a weighted backpack, walk 10 meters, climb stairs, move objects between shelves (1 kg each), and return. They perform tasks sequentially, transferring items up and down shelves. The route is retraced, ending by sitting back in the initial chair, measured in seconds
Time frame: Baseline and 12 weeks
The test consists in rising from a chair as many times as possible within 30 seconds, measured in number of repetitions
Time frame: Baseline and 12 weeks
The Post-COVID-19 Functional Status Scale assesses limitations following SARS-CoV-2 infection, measured as a score
Time frame: Baseline and 12 weeks
The Patient Functional Scale allows individuals to identify 3 to 5 important activities they consider themselves unable to perform or are having difficulty with due to their condition, measured in a score
Time frame: Baseline and 12 weeks
The cortical excitability of the quadriceps motor area will be measured using Motor Evoked Potential results in microvolts (µV) using the Transcranial Magnetic Stimulation equipment model MagPro R20 (MagVenture, Denmark) with the parabolic coil model MMC-140-II, measured in kgf
Time frame: Baseline and 12 weeks
This scale comprises five items, allowing the patient to select the item that corresponds to how much their dyspnea limits their daily life activities, measured as a score
Time frame: Baseline and 12 weeks
Comprising eight specific statements about physical fatigue to confirm its presence or absence, measured as a score
Time frame: Baseline and 12 weeks
The questionnaire evaluate the symptoms of fatigue in different conditions, measured as a score
Time frame: Baseline and 12 weeks
To assess quality of life, the 12-Item Short-Form Health Survey will be used, consisting of twelve items that evaluate eight different dimensions influencing quality of life, measured as a score
Time frame: Baseline and 12 weeks
Frailty will be assessed using the Tilburg Frailty Indicator, while sarcopenia will be evaluated through the Sarcopenia Form questionnaire, both measured as a score
Time frame: Baseline and 12 weeks
Levels of anxiety and depression will be assessed using the Hospital Anxiety and Depression Scale, measured as a score
Time frame: Baseline and 12 weeks
Assessed using the Numeric Pain Rating Scale, measured as a score
Time frame: Baseline and 12 weeks
Movement behavior will be quantified through a motion sensor, measured in minutes
Time frame: Baseline and 12 weeks
Specific questionnaire to assess the most prevalent environmental barriers to physical activity, measured as presence or absence
Time frame: 12 weeks
Adherence to exercise interventions will be obtained with the Adherence Assessment Scale
Time frame: Baseline and 12 weeks
The clinical resting blood pressure will be assessed using automatic blood pressure monitoring equipment (HEM-7113, OMRON®, Brazil), measured in mmHg
Time frame: Baseline and 12 weeks
Cardiac autonomic modulation will be assessed through heart rate variability using a heart rate monitor, measured in RR intervals
Time frame: Baseline and 12 weeks
The measurements of basal blood flow and flow-mediated vasodilation will be obtained through ultrasonography in brachial artery, measured in ml/min or %
Time frame: Baseline and 12 weeks
Changes in Forced vital capacity, forced expiratory volume in the first second, Peak expiratory flow, forced expiratory flow 25-75% and FEV 1 /FVC ratio
Time frame: 12 weeks
Scale used to assess the individuals' perception of the app's usability in the group submitted to the intervention
Time frame: 12 weeks
The questionnaire will be applied in experimental group to collect information regarding the user's overall experience with the app, such as: general perception, overall experience, main barriers, and key difficulties in using the app.
Time frame: 12 weeks
The focus group will be conducted via video conference with 4 to 10 individuals that participated in experimental group. The guiding questions will aim to understand the user's perception, from usability to effectiveness, including satisfaction and potential improvements to the app.
Contact information is provided by the study sponsor or research team.
Fernanda Corrêa, PhD
CONTACT
Raphael Ritti-Dias, PhD
CONTACT
University of Nove de Julho
Other
Effects of a Physical Training Program Using a Mobile App on the Functionality and Cardiovascular Function of Individuals With Post-covid-19 Syndrome: Randomized Clinical Trial
Acronym: Recovery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05094622
Autonomic Nervous System Diseases, Behavior
Stockholm, Sweden
View Trial DetailsNCT05597774
Behavior, COVID-19
Madrid, Spain
View Trial DetailsNCT05977179
COVID-19, Chronic Disease
Baltimore, Maryland, United States
View Trial DetailsNCT06095297
Behavior, Behavioral Symptoms
Birmingham, Alabama, United States
View Trial Details